Prime Medicine Inc (PRME)
7.535
+0.50
(+7.03%)
USD |
NASDAQ |
May 20, 16:00
7.46
-0.08
(-1.00%)
After-Hours: 20:00
Prime Medicine Cash from Operations (Quarterly): -67.71M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -67.71M |
| December 31, 2023 | -43.86M |
| September 30, 2023 | -39.17M |
| June 30, 2023 | -40.82M |
| March 31, 2023 | -41.56M |
| Date | Value |
|---|---|
| December 31, 2022 | -30.71M |
| September 30, 2022 | -30.10M |
| June 30, 2022 | -20.22M |
| March 31, 2022 | -50.79M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-67.71M
Minimum
Mar 2024
-20.22M
Maximum
Jun 2022
-40.55M
Average
-40.82M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Pacific Biosciences of California Inc | -75.68M |
| 10x Genomics Inc | -15.72M |
| Recursion Pharmaceuticals Inc | -102.30M |
| Verve Therapeutics Inc | -43.08M |
| Ginkgo Bioworks Holdings Inc | -89.26M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -37.03M |
| Cash from Financing (Quarterly) | 157.33M |
| Free Cash Flow | -200.61M |
| Free Cash Flow Per Share (Quarterly) | -0.6704 |
| Free Cash Flow to Firm (Quarterly) | -70.03M |
| Free Cash Flow Yield | -28.08% |